NDC 0121-1075 – Brivaracetam
Brivaracetam 50 mg/5mL · Injection · Intravenous
Product NDC0121-1075
Product details
- Brand name
- Brivaracetam
- Generic name
- Brivaracetam Injection
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- ANDA · ANDA218249
- Marketed since
- February 23, 2026
- Listing expires
- December 31, 2027
Active ingredients
- Brivaracetam 50 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0121-1075-02 | 10 VIAL, GLASS in 1 CARTON (0121-1075-02) / 5 mL in 1 VIAL, GLASS (0121-1075-55) | Feb 23, 2026 |
Other brivaracetam products
- 60505-4727 Brivaracetam 100 mg/1 · Tablet · Apotex Corp.
- 60505-4723 Brivaracetam 10 mg/1 · Tablet · Apotex Corp.
- 60505-4724 Brivaracetam 25 mg/1 · Tablet · Apotex Corp.
- 60505-4725 Brivaracetam 50 mg/1 · Tablet · Apotex Corp.
- 60505-4726 Brivaracetam 75 mg/1 · Tablet · Apotex Corp.
- 84386-071 Brivaracetam 75 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 84386-068 Brivaracetam 10 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 84386-070 Brivaracetam 50 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 84386-072 Brivaracetam 100 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 84386-069 Brivaracetam 25 mg/1 · Tablet, Film Coated · Aurobindo Pharma Limited
- 59651-995 Brivaracetam 10 mg/mL · Solution · Aurobindo Pharma Limited
- 73190-075 Brivaracetam 50 mg/1 · Tablet, Film Coated · AvKARE